Understanding a Gene's Role in New Breast Cancer Cases
Part of Cancer, Skin clinical trials.
This study looks at a specific gene called PCGEM1 in people newly diagnosed with breast cancer to understand how it affects the disease. Researchers hope this information will eventually help develop better treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have been recently diagnosed with breast cancer confirmed by a tissue sample (biopsy)
- You have not been treated for breast cancer before with chemotherapy or radiation
- You do not have a history of other cancers
- You do not have other serious long-term health conditions like diabetes or heart disease
- Your medical records and test results are complete and available
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at which DNA “repair” gene changes are found in breast cancer patients, especially certain subtypes and high-risk situations. Your genetic test results may help researchers understand who has specific DNA repair pathway mutations and how they relate to breast cancer.
This study tests a tool to help people newly diagnosed with early-stage breast cancer better understand their gene test results. It is for patients who haven't yet decided about chemotherapy and want to learn more about their options.
This study links breast tumor test results from MammaPrint and optional BluePrint (and full genetic data) with real-world clinical information to understand which new gene activity patterns matter. It may help future patients by improving how doctors use these tests to guide care.
This study looks at the genes in your cancer to find a treatment that might work better for you. It tests your tumor sample to match you with a drug that targets your cancer's specific weaknesses.
This study looks at specific molecules in the body that can change how your genes work (epigenetic mediators) in women who have just been diagnosed with breast cancer. The goal is to understand these markers better, which could help improve treatment in the future.
This study tests the genes of your cancer to learn more about advanced breast, lung, melanoma, or sarcoma tumors. It may help doctors find better ways to treat these cancers in the future.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.